Antibody responses of splenectomized patients with non-Hodgkin's lymphoma to immunization with polyvalent pneumococcal vaccines

Clinical and Diagnostic Laboratory Immunology

Volumn 4, Issue 6, 1997, Pages 635-638

  Petrasch, S ^a   Kuhnemund O ^b   Reinacher, A ^a   Uppenkamp, M ^c   Reinert, R ^b   Schmiegel, W ^a   Lutticken R ^b   Brittinger, G ^c  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; GERMANY; HUMAN; IMMUNIZATION; INJECTION; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REVACCINATION; SPLENECTOMY; STREPTOCOCCUS PNEUMONIAE;

EID: 0030772321     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.4.6.635-638.1997     Document Type: Article

References (38)

1. Aaberge, I. S., and H. E. Heier. 1984. Long-term effect of pneumococcal polysaccharide vaccination on serum IgM and IgG antibody levels in individuals splenectomized for trauma. Acta Pathol. Microbiol. Immunol. Scand. Sect. C 92:363-369.
2. Addiego, J. E., A. J. Ammann, G. Schiffman, R. Baehner, G. Higgins, and D. Hammond. 1980. Response to pneumococcal polysaccharide vaccine in patients with untreated Hodgkin's disease. Lancet ii:450-452.
3. Amlot, P. L., and L Green. 1979. Serum immunoglobulins G, A, M, D and E concentrations in lymphomas. Br. J. Cancer 40:371-379.
4. Austrian, R., R. M. Douglas, G. Schiffman, et al. 1976. Prevention of pneumococcal pneumonia by vaccination. Trans. Assoc. Am. Physicians 89:184-194.
5. Ballester, O. F., M. Shurafa, H. Toben, K. S. Kumar, and C. L. Burek. 1981. Impaired antibody responses to a pneumococcal polysaccharide vaccine in patients with non-Hddgkin's lymphoma in remission. J. Clin. Immunol. 1: 90-93.
6. Barrett, D. J., M. Triggiani, and E. M. Ayoub. 1983. Assay of antibody to group A streptococcal carbohydrate by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 18:622-627.
7. Borgono, J. M., A. A. McLean, P. P. Vella, et al. 1978. Vaccination and revaccination with polyvalent pneumococcal polysaccharide vaccines in adults and infants. Proc. Soc. Exp. Biol. Med. 157:148-154.
8. Carlson, B. A., G. S. Giebink, J. S. Spika, and E. D. Gray. 1982. Measurement of immunoglobulin G and M antibodies to type 3 pneumococcal capsular polysaccharide by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 16:63-69.
9. Caulfield, M. J., and D. A. Shaffer. 1984. Computer program for the evaluation of ELISA data obtained using an automated microtiter plate absorbance reader. J. Immunol. Methods 74:205-215.
10. Chaikof, E. L., and C. J. McCabe. 1985. Fatal overwhelming postsplenectomy infection. Am. J. Surg. 149:534-539.
11. Donaldson, S. S., K. L. Vosti, F. R. Berberich, R. S. Cox, H. S. Kaplan, and G. Schiffman. 1981. Response to pneumococcal vaccine among children with Hodgkin's disease. Rev. Infect. Dis. 3:S133-S143.
12. Eby, R. 1995. Pneumococcal conjugate vaccines, p. 695-718. In M. F. Powell and M. J. Newman (ed.), Pharmaceutical biotechnology, vol. 6. Vaccine design: the subunit and adjuvant approach. Plenum Press, New York, N.Y.
13. Frederiksen, B., L. Specht, J. Henrichsen, F. K. Pedersen, and J. Pedersen-Bjergaard. 1989. Antibody response to pneumococcal vaccine in patients with early stage Hodgkin's disease. Eur. J. Haematol. 43:45-49.
14. Fuchshuber, A., O. Kühnemund, B. Keuth, R. Lüttiken, D. Michalk, and U. Querfeld. 1996. Pneumococcal vaccine in children and young adults with chronic renal disease. Nephrol. Dial. Transplant. 11:468-473.
15. Giebink, G. S., J. E. Foker, Y. Kim, and G. Schiffman. 1980. Serum antibody and opsonic responses to vaccination with pneumococcal capsular polysaccharide in normal and splenectomized children. J. Infect. Dis. 141:404-412.
16. Gopal, V., and A. L. Bisno. 1977. Fulminant pneumococcal infections in 'normal' asplenic hosts. Arch. Intern. Med. 137:1526-1530.
17. Grimfors, G., M. Björkholm, L. Hammarström, J. Askergren, C. I. E. Smith, and G. Holm. 1989. Type-specific antipneumococcal antibody subclass response to vaccination after splenectomy with special reference to lymphoma patients. Eur. J. Haematol. 43:404-410.
18. Grimfors, G., M. Söderqvist, G. Holm, A. K. Lefvert, and M. Björkholm. 1990. Longitudinal study of class and subclass antibody response to pneumococcal vaccination with splenectomized individuals with special reference to patients with Hodgkin's disease. Eur. J. Hematol. 45:101-108.
19. Henrichsen, J. 1995. Six newly recognized types of Streptococcus pneumoniae. J. Clin. Microbiol. 33:2759-2762.
20. Holdrinet, R. S. 1981. Postsplenectomy sepsis. Neth. J. Med. 304:245-250.
21. Jones, S. E., K. Griffith, P. Dombrowski, and J. A. Gaines. 1977. Immunodeficiency in patients with non-Hodgkin lymphomas. Blood 49:335-344.
22. Kaplan, M. H., A. H. Coons, and H. W. Deane. 1950. Localization of antigen in tissue cells. Cellular distribution of pneumococcal polysaccharides types II and III in the mouse. J. Exp. Med. 91:15-29.
23. Kaufhold, A., R. Lütticken, and J. Henrichsen. 1987. Capsular types and antibiotic susceptibility of Streptococcus pneumoniae isolated from patients with systemic infections in West Germany. Eur. J. Clin. Microbiol. 6:696-697.
24. Kühnemund, O., A. Stütz, A. Fuchshuber, U. Querfeld, S. Petrasch, R. R. Reinert, and R. Lütticken. Immune response to the 23-valent pneumococcal polysaccharide vaccine in lymphoma patients and patients with chronic renal disease. In Streptococci and the host. Proceedings of the XIIIth Lancefield International Symposium on Streptococci and Streptococcal Diseases, Paris 1996, in press. Plenum Publishing Corp., New York, N.Y.
25. Levine, A. M., G. D. Overturf, R. F. Field, D. Holdorf, A. Paganini-Hill, and D. I. Feinstein. 1979. Use and efficacy of pneumococcal vaccine in patients with Hodgkin's disease. Blood 54:1171-1175.
26. Lin, K. T., and C. J. Lee. 1982. Immune response of neonates to pneumococcal polysaccharide-protein conjugate. Immunology 46:333-342.
27. Molrine, D. C., S. George, N. Tarbell, P. Mauch, L. Diller, D. Neuberg, R. C. Shamberger, E. L. Anderson, N. R. Phillips, K. Kinsella, and D. M. Ambrosino. 1995. Antibody response to polysaccharide and polysaccharide-conjugate vaccines after treatment of Hodgkin's disease. Ann. Intern. Med. 123: 828-834.
28. Offenbartl, K., P. Christensen, P. Gullstrand, K. Prellner, and J. Henrichsen. 1981. Effect of gamma globulin infusion on type specific pneumococcal antibody levels in splenectomized adults. Int. Arch. Allergy Appl. Immunol. 81:209-213.
29. Reinert, R. R., A. Kaufhold, O. Kühnemund, and R. Lütticken. 1994. Serum antibody responses to vaccination with 23-valent pneumococcal vaccine in splenectomized patients. Zentralbl. Bakteriol. 281:481-490.
30. Reinert, R. R., A. Kaufhold, and H. Kierdorf. 1992. Penicillin-resistant Pneumococcus in community acquired bacteremic pneumonia. Infection 20:238-239.
31. Rivilla-Parra, F., M. Gamez-Aranle, and J. Gonzalez-Utrilla. 1987. Evaluation study of laparotomy in Hodgkin's disease. An. Esp. Pediatr. 26:37-39.
32. Schneerson, R., J. B. Robbins, J. C. Parke, Jr., C. Bell, J. J. Schlesselman, A. Sutton, Z. Wang, G. Schiffman, A. Karpas, and J. Shiloach. 1986. Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates. Infect. Immun. 52:519-528.
33. Shapiro, E. D., A. T. Berg, R. Austrian, et al. 1991. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N. Engl. J. Med. 325:1453-1460.
34. Siber, G. R., S. A. Weitzman, A. C. Aisenberg, H. J. Weinstein, and G. Schiffman. 1978. Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin's disease. N. Engl. J. Med. 299:442-448.
35. Siber, G. R., C. Gorham, P. Martin, J. C. Corkery, and G. Schiffman. 1986. Antibody response to pretreatment immunization and posttreatment boosting with bacterial polysaccharide vaccines in patients with Hodgkin's disease. Ann. Intern. Med. 104:467-475.
36. Smit, P., D. Oberholzer, S. Hayden-Smith, H. J. Koornhof, and M. R. Hilleman. 1977. Protective efficacy of pneumococcal polysaccharide vaccines. JAMA 238:2613-2616.
37. Weitzmann, S., and A. C. Aisenberg. 1977. Fulminant sepsis after the successful treatment of Hodgkin's disease. Am. J. Med. 62:47-50.
38. Wilson, S. A., and W. D. Johnson. 1980. Infection complicating surgical or functional splenectomy and gastrectomy, p. 848-865. In M. H. Grieco (ed.), Infections in the abnormal host. Yorke Medical Books, New York, N.Y.